Green Synthesis Of Biocompatible Nonoparticles For Enhanced Antibacterial Activity Of Conventional Antibiotics "Compare Free Drug Vs Nano-Assisted Drug

Abstract

The increasing prevalence of antibiotic-resistant bacterial infections poses a serious threat to global public health and highlights the urgent need for strategies that enhance the efficacy of existing antimicrobial agents. This study investigates the green synthesis of biocompatible nanoparticles and their application as nano-assisted systems to improve the antibacterial performance of conventional antibiotics. Plant-derived extracts were employed as eco-friendly reducing and stabilizing agents, ensuring sustainability, low toxicity, and suitability for biomedical use.The antibacterial activity of free antibiotics was directly compared with nanoparticle-assisted formulations using simple agar diffusion assays against representative Gram-positive and Gram-negative bacterial strains. Nano-assisted antibiotics consistently produced larger zones of inhibition than their free-drug counterparts, even at lower concentrations, indicating significantly enhanced antibacterial potency. The green synthesis approach further enhances biocompatibility and addresses safety concerns associated with chemically synthesized nanomaterials, supporting clinical relevance. In addition to therapeutic implications, the distinct and reproducible inhibition zone patterns observed in agar diffusion tests demonstrate the potential of these nano-assisted systems for diagnostic and sensor chemistry applications. The visible antibacterial response enables rapid, low-cost screening of antibiotic efficacy and susceptibility, suggesting future integration into point-of-care diagnostic platforms. Overall, this study highlights green-synthesized nanoparticle-assisted antibiotics as a promising strategy to revitalize conventional antimicrobials while bridging therapeutic innovation with diagnostic and sensing technologies.